Adaptyv Bio
PrivateLast Round
Series A
Aug 26, 2026
Total Funding Raised
$50.85M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Adaptyv Bio is a biotechnology company that develops a next-generation protein engineering foundry integrating artificial intelligence, robotics, and nanofluidics to accelerate the design, synthesis, and testing of novel proteins.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, ML Platforms
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adaptyv Bio Comparables
Compare Adaptyv Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ailurus Biotechnology | 79% | |
| Arctoris | 78% | |
| Tierra Biosciences | 78% |
Adaptyv Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 26, 2026 | ||||
| Seed | Sep 25, 2025 | ||||
| Debt | Jun 1, 2023 | ||||
| Pre Seed | Feb 14, 2022 | ||||
| Seed | Aug 4, 2021 | ||||
Grant | Apr 28, 2021 |
Adaptyv Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LongGame Ventures | Seed |
| Foundation for Technological Innovation | Debt |
| Acequia Capital | Pre Seed |
| Founders, Inc. | Pre Seed |
| ACE Ventures | Seed |
| Hawktail Management | Pre Seed |
| Rheingau Founders | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 26, 2026
$40M round led by Highland Europe.
- Apr 18, 2026
Added Cradle, a biotechnology/AI startup, as a customer.
Recent news
Latest coverage and updates
- has_revenueSep 2, 2026
Adaptyv Bio had revenue of $2.6M on Dec 1st '24.
- receives_financingAug 29, 2026
Adaptyv Bio receives financing of $46.6M in Series A.
- receives_financingAug 27, 2026
Adaptyv Bio received financing of $40M in Series A on Aug 27th '26.
- integrates_withAug 27, 2026
Adaptyv Bio integrated with Latent Labs Ltd. on Jul 1st '26.
- expands_facilitiesAug 27, 2026
Adaptyv Bio expanded facilities to Lausanne, Switzerland, Western Europe, Europe on Jul 1st '26.
Adaptyv Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Adaptyv Bio's valuation, stock price, and market status.
Is Adaptyv Bio a public or private company?
Adaptyv Bio is a private company.
What is the current stock price of Adaptyv Bio?
Adaptyv Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Adaptyv Bio worth (valuation)?
Valuation information for Adaptyv Bio is not publicly available.
Can I buy Adaptyv Bio stock?
Adaptyv Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Adaptyv Bio's last funding round?
Adaptyv Bio's most recent funding round was Seed on September 26, 2025.
Who are the main investors in Adaptyv Bio?
Key investors in Adaptyv Bio include ACE Ventures, Founderful.
Will Adaptyv Bio IPO soon?
No public IPO plans have been announced for Adaptyv Bio.
How can I track Adaptyv Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Adaptyv Bio's secondary market activity and sign up for updates.